Products mentioned by Lloyd Klickstein

“BPC-157 carries additional red flags: it is not encoded in the human genome, has no identified receptor, has no known mechanism of action, and all published data originate from a single investigator whose findings have not been independently reproduced.”

by Novartis

“Lloyd Klickstein, physician-scientist and drug developer with 20+ years at Novartis and multiple biotech companies, traces the complete arc of modern drug development using bimagrumab as a case study”

by AbbVie

“Companies like AbbVie extended Humira's protection by staggering patents on composition of matter, formulation, salts, auto-injector, dosing route, and manufacturing process.”